Beetroot Juice: A Natural Boost for Cardiovascular Health in Postmenopausal Women?
NCT ID: NCT06598488
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2024-09-02
2028-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nitrate, Exercise and Vascular Function in Midlife Women
NCT06527248
NO3-rich Beet Juice and Exercise on Postmenopausal Women Cardiovascular Health
NCT05384340
Effect of Beetroot Juice on Blood Pressure Regulation in Post Menopausal Women
NCT03380000
BEETROOT JUICE INTAKE in POSTMENOPAUSAL HYPERTENSIVE WOMEN
NCT06584331
Effects of Beetroot Juice in Postmenopausal and Hypertensive
NCT03620227
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary objective is to investigate whether short-term BRJ supplementation can reduce resting and exercise blood pressure and enhance oxygen uptake during maximal exercise, compared to a placebo. The study will also explore the relationship between these cardiovascular responses and blood biomarkers, including nitrate/nitrite levels and inflammatory cytokines.
The study design is a randomized, double-blind, placebo-controlled crossover trial. Post-menopausal women will be randomized into either the BRJ or placebo group, consuming BRJ or nitrate-depleted juice for 4 days, followed by a 7-day washout period before switching to the alternate group. Participants will undergo testing to measure blood pressure and oxygen uptake at rest and during exercise at baseline and after each intervention.
This research is novel and clinically significant, as it explores a non-pharmacological approach to mitigate cardiovascular risks in post-menopausal women. By improving cardiovascular function, this study aims to offer a new strategy for addressing age- and menopause-related increases in blood pressure and declines in exercise capacity.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nitrate rich beetroot juice
4 days of nitrate rich beetroot juice ingestion (Beet it)
Beetroot juice
Beetroot juice will be consumed 2 times a day for 4 days before testing plus one shot on experimental testing day 1,5 hours before arrival.
Nitrate depleted beetroot juice
4 days of nitrate depleted beetroot juice ingestion (Beet it)
Beetroot juice placebo
Beetroot juice will be consumed 2 times a day for 4 days before testing plus one shot on experimental testing day 1,5 hours before arrival.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Beetroot juice
Beetroot juice will be consumed 2 times a day for 4 days before testing plus one shot on experimental testing day 1,5 hours before arrival.
Beetroot juice placebo
Beetroot juice will be consumed 2 times a day for 4 days before testing plus one shot on experimental testing day 1,5 hours before arrival.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Self-reported absence of menstrual cycle for \>1 year
* BMI \<30 kg/m2.
* Able to walk on a treadmill and cycle on a stationary bike without problems.
* Proficient in Norwegian and able to provide informed consent.
Exclusion Criteria
* Addictions to alcohol or illegal drugs
* Allergy or intolerance (s) to nitrate or BRJ supplement.
* Diagnosed with cardiovascular disease (e.g., previous acute myocardial infarction or stroke, peripheral artery disease, heart failure), renal, or respiratory (e.g., asthma, sleep apnea).
* Regular usage of nitrate supplements, including beetroot juice
* Hormone replacement therapy.
* Uncontrolled high blood pressure (e.g., resting systolic and diastolic blood pressure \&gt;160/110 mmHg)
* Problems with very low blood pressure (e.g., severe dizziness upon standing)
* Diagnosed with diabetes (type 1 or type 2).
* Using blood pressure or glucose-lowering medications
* Close family (parents, siblings, children) history of sudden cardiac death at an early age (\&lt;55 for men, \&lt;65 for women)
* Judgment by a medical provider that exercise poses an undue burden or risk.
* Cognitive or psychiatric impairment
* Lack of proficiency in Norwegian language oral or writing skills that will hamper the ability to participate in the interventions and fill out questionnaires.
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Western Norway University of Applied Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ann-Katrin Grotle
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Western Norway University of Applied Sciences
Bergen, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
730456
Identifier Type: OTHER
Identifier Source: secondary_id
730456
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.